UCB PHARMA A.S.

UCB PHARMA A.S. is a manufacturer.

Company Introduction:

UCB PHARMA A.S. is the Turkish subsidiary of UCB, a global biopharmaceutical company headquartered in Belgium. UCB is dedicated to the research, development, and commercialization of innovative medicines and solutions focused on neurology, immunology, and rare diseases.

As a part of the global UCB group, UCB PHARMA A.S. in Turkey plays a crucial role in bringing these innovative treatments to the Turkish market. While the global parent company, UCB, is a primary manufacturer with extensive research and production facilities worldwide, UCB PHARMA A.S. in Turkey primarily manages the sales, marketing, distribution, and local clinical development activities for UCB's pharmaceutical products within Turkey. It ensures that UCB's global manufacturing output reaches patients and healthcare providers in the region. Therefore, it is categorized as part of a manufacturing enterprise rather than a pure trading company.

Here are some products manufactured or marketed by UCB PHARMA A.S. in Turkey:

* **Cimzia** (certolizumab pegol)

* **Keppra** (levetiracetam)

* **Briviact** (brivaracetam)

* **Neupro** (rotigotine)

* **Xyzal** (levocetirizine dihydrochloride)

Please note that product availability may vary. It is always best to consult directly with UCB Pharma A.S. or a healthcare professional for the most accurate and up-to-date information.